Upregulation of PD-L1 on tumor cells by chemotherapy may therefore allow tumors to escape from immune surveillance [28], in which case, anti-PD-L1/PD-1 checkpoint-inhibition could have a role to play in chemotherapeutic regimens. The gene discussed is CD274; the disease is neoplasm.